Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Tiffany Meng, PharmD, an oncology pharmacist, UCSF Health, shares how pharmacists can collaborate with physicians to find the ...

Experts discuss how they balance safety, efficacy, and overall patient prognosis when selecting third-line treatments for metastatic colorectal cancer (mCRC) and explore how the toxicity profiles of ...

To mark the 30th anniversary of The American Journal of Managed Care, each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for ...

This investigation analyzes public data on adult patients from the 2017 National Health Interview Survey, including how often ...

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal ...

A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation therapy, in ...

Seemal R Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), emphasized his commitment to enhancing the upcoming 2025 annual meeting by introducing new events and expanding ...

Brianna Rhue, OD, FAAO, discusses the pitfalls of myopia treatment and accessibility of that treatment. There are still some ...

These findings may not be generalizable to uninsured patients with ovarian cancer, who face unique barriers to care compared ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

Rising rates of metabolic dysfunction–associated steatohepatitis indicate a need for public health interventions.